Article 9 of the new UAE transplant regulations covers complications regardless of when they appear. An open-ended tail is now written into every health insurance policy in the country.

The resolution obliges insurance companies in the State to include, within the health insurance policies and relevant annexes they issue, all health services connected to removal and transplantation operations provided to both the donor and the recipient, before, during and after the operation. It requires them to bear the cost of that cover across all health insurance systems in force in the country.

Then it adds the clause that changes the shape of the exposure: the obligation extends to treatment of complications arising from those operations regardless of the period during which the complications appear or are discovered. Insurance liabilities are normally bounded by a policy period, a notification window, or both. This provision states that neither bounds this one.

A transplant recipient who develops a related complication years after the procedure, under a policy that has since lapsed or moved to another carrier, sits inside a duty the regulation places on insurers in the State without a stated end date.

The same article settles a question that has produced disputes across the region. In all cases, the cost of transplanting an organ includes the costs associated with removing the organ or tissue from the living or deceased donor, together with follow-up costs after removal and transplantation and any complications resulting from them. Donor-side cost has often been argued about precisely because the donor is not the insured patient.

The regulation closes that argument by writing donor costs into the definition of the recipient's transplant cost. For a hospital, this clarifies who pays for the donor episode. For an insurer, it enlarges the covered event and does so on both sides of a procedure it may have priced from recipient data alone.

Article 14 provides that the resolution is published in the Official Gazette and comes into force from the day following the date of publication, with one exception: Article 9 applies only after six months have passed from the date of publication.

The regulator gave the insurance obligation a lead time it gave nothing else in the instrument, which is a reasonable signal of how much repricing it expects the market to do. That six-month clock runs from gazette publication rather than from the 20 April issue date, so the operative date for the insurance industry is a matter of the gazette record and should be established from it rather than inferred.

For hospitals, Article 2 requires the Ministry or the relevant health authority to verify a set of conditions before licensing a facility to perform removal or transplantation. The facility must hold the equipment, medical supplies and infrastructure required for the procedures, in accordance with requirements to be set by Ministerial decision and with the procedures manual for donation and transplantation issued by the National Centre in coordination with the health authorities.

It must have specialist professional staff for the procedure itself, and separately for the function of introducing and raising awareness of the donation programme and facilitating donation procedures. It must have a laboratory accredited to the standards applied by the Ministry or the health authority. And it must adopt a plan ensuring the safety of medical equipment and devices.

The licence term is set by the Ministry or health authority at not less than one year, with renewal conditions in Article 3. The awareness-staffing requirement is the one a business case is least likely to have costed, because it funds a function that generates no billable activity of its own.